WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments at HealthBulance.

Health care is our expertise. On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P.

WHO Org

WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments

WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection.